No abstract available
Keywords:
HLA; PD-1 inhibitor; Primary mediastinal B-cell lymphoma.
MeSH terms
-
Adult
-
Drug Resistance, Neoplasm* / drug effects
-
Drug Resistance, Neoplasm* / genetics
-
Female
-
Genotype
-
HLA Antigens / genetics*
-
Humans
-
Lymphoma, B-Cell* / drug therapy
-
Lymphoma, B-Cell* / genetics
-
Lymphoma, B-Cell* / pathology
-
Mediastinal Neoplasms* / drug therapy
-
Mediastinal Neoplasms* / genetics
-
Mediastinal Neoplasms* / pathology
-
Nivolumab / therapeutic use*
-
Pharmacogenomic Testing
-
Recurrence
-
Treatment Outcome